 Merck no good.. POCH Study of Verubecestat for the Treatment of People with Mild to Moderate Alzheimer‚Äôs Disease to Stop for Lack of Efficacy
 Merck  Merck.XE:

Merck Stops Clinical Trial of Alzheimer‚Äôs Drug:


Largest gainers today on my Watch List were:  Merck  ABMD  SAM  MCK  UA - 
 sciencescanner Maybe  Merck at least will learn D. Schoepp proclaimed this in 2013:"Now we can get an answer on the amyloid hypothesis" (1/2)
 Merck Merck Alzheimer's drug fails in 1 study; another continues 
Unfortunate news for  Merck and for those with Alzheimer's  LifeSciences 
Alzheimer‚Äôs has claimed another victim  Merck
 Merck has pulled the plug on a closely watched trial in Alzheimer‚Äôs disease üîí 
 Merck Merck to halt study of mild to moderate Alzheimer's drug 
Paulson Goes 13G Grabbing More Valeant Shares in Q4  VRX  AGN  MYL  Merck  JNJ  BRK  Apple  KO  PEP  EXEL  CAKE  tst‚Ä¶ 
Should see a nice pop tomorrow in  NTRP due to  Merck news 
 NTRP doesn't use such sentence (so far)  Merck: "with APECS, which is studying verubecestat in people with less advanced disease.‚Äù
Scratch yet another Phase III Alzheimer‚Äôs drug hopeful.  Merck 
Failure of  verubecestat in EPOCH study not too shocking- assessed in mild to moderate Alzheimer's  Merck 
Merck‚Äôs leading PhIII BoeingCE drug implodes in latest Alzheimer‚Äôs disaster
 Merck  LLY  AXON  BIIB

 LGND unchanged after hours on  Merck BoeingCE news? Surprising
 biggercapital  Merck just halted Alzheimer's trial .. That path way is dead... HELLO   NTRP &  ARFXF
 Merck falls after hrs on the news that the company will stops trial on Alzheimer's drug. 
 Merck The 17-Feb-17 option ATM straddle implied a move of ¬±1.1% by expiration.  
 Merck looking great on an uptrend plus recently broke out  GuyAdami  BKBrianKelly  RiskReversal  timseymour‚Ä¶ 
fshew. glad i was on record saying i booked  Merck call profits today ;-) AH bad news on it.
 Merck alzheimers  p3 trial FAILS and is stopped,stanford U is doing amazing things w/alz research using  human plasma from YOUNG people WOW
 Merck Company halts the EPOCH study of Verubecestat for those with mild to moderate Alzheimer‚Äôs 
Merck halts Alzheimer‚Äôs trial; down 1%  Merck  sitifatimah  malaysia  financialplanning
 Merck Announces EPOCH Study of BoeingCE inhibitor Verubecestat for Mild to Moderate  Alzheimers Disease to Stop for Lack‚Ä¶ 
MarketCurrents: Merck halts Alzheimer‚Äôs trial; down 1%  Merck
Merck halts Alzheimer‚Äôs trial; down 1%  Merck
 Merck is stopping its Alzheimer's trial because there's ‚Äúvirtually no chance of finding a positive clinical effect.‚Äù 
 AndyBiotech  Merck stops  Alzheimer's study for futility - the final nail in the coffin for the Amyloid Hypothesis.
 Merck stops one study of its BoeingCE. More bad news for amyloid as a drug target. 
megtirrell:  Merck stops study of BoeingCE inhibitor in mild to moderate Alzheimer's for lack of efficacy, prodromal study continues
 Merck stops early a study of its BoeingCE inhibitor Alzheimer's drug "for lack of efficacy" Still studying in earlier pts
 Merck stops study of BoeingCE inhibitor in mild to moderate Alzheimer's for lack of efficacy, prodromal study continues
Damn, another loss as  Merck stops BoeingCE inhibitor study for Alzheimer's disease. This was supposed to put the amyloid hypothesis issue to rest
 Merck BoeingCEi in Ph2/3 mild-to-moderate  Alzheimer‚Äôs disease will be stopped --> ‚Äúvirtually no chance of finding a positive clinical effect.‚Äù
 Merck Merck Announces EPOCH Study of Verubecestat for the Treatment of People with Mild to Moderate Alzheimer‚Äô... 
 Merck:

Merck (Merck) Stops EPOCH Study of Verubecestat in Mild to ‚Ä¶:


 Merck Merck Announces EPOCH Study of Verubecestat for the Treatment of People with Mild to Moderate Alzhei... - 
 Merck EPOCH ph2/3 Study of Verubecestat (BoeingCE) in Mild to Moderate Alzheimer‚Äôs Disease to Stop for Lack of Efficacy 

Another Phase III Alzheimer's trial bites the dust (tho expectations were quite low)  Merck 
 Merck:  EPOCH Study of Verubecestat for the Treatment of People with Mild to Moderate Alzheimer‚Äôs Disease to Stop for Lack of Efficacy
 Merck stopping BoeingCE study. Lack of efficacy. Prodromal continues
 Merck:

Merck Announces EPOCH Study of Verubecestat for the Treatment ‚Ä¶:


 Merck:

Merck (Merck) Says Its Phase 3 Trial of Doravirine for HIV-1 Infection ‚Ä¶:


Leerink - also  Merck  SGEN  HOLX  DEPO  BMY  REGN  BMRN  CYNO
MarketCurrents: Merck HIV treatment meats primary endpoint in Phase 3 trial  Merck
Merck HIV treatment meats primary endpoint in Phase 3 trial  Merck  sitifatimah  malaysia  financialplanning
Merck HIV treatment meats primary endpoint in Phase 3 trial  Merck
 Merck says Phase 3 doravirine study meets primary efficacy endpoint 
/2 Biotech/HC New or revisited 52-week highs:  GRFS  HCA  ICLR  INCY  KMDA  MDCO  Merck  NBRV  PLSE  PRAH  Q  RMD  USPH  WMGI  THERF  SPY  QQQ
 Merck Announces its Phase 3 trial of doravirine (MK-1439) met its primary efficacy endpoint of the proportion of pa‚Ä¶ 
Dow  Stocks Trend  MSFT  CAT  Intel  Merck  DD  Boeing  CSCO  Apple  IBM  MCD  JPM  DIS  UNH  V  HD  TRV  MMM  AXP  GS    
Risk Reversal Trades 2,000 Times in  Merck 
 Merck Some of biotech's biggest names have acquired this Md. company 
Therapy Focus - Immunotherapy Closes In On Triple-Negative Tumors  CELG  RHHBY  Merck  AZN  NVS  BMY  IBB
Addressable Markets  AXP  BoeingC  DIS  HD  JNJ  JPM  JWN  LEN  Merck  NVR  PFE  WFC  AMGN  AMZN  NFLX  TGNA  PYPL 
 RedDogT3  mrk  but mrk part of ibb so strong?? 
booked  Merck calls. opened 2/2. pure profit since financed using sold puts. but calls alone would be +50% on risk
 Merck One word "KEYTRUDA"
taking partial profits on  Merck
 Merck Life Sciences Pennsylvania Names Finalists for 2016 Patient Impact Award. Read more:  Merck
 Merck chart update as of now: and why I like it long in a bullish mkt 
 Merck long trade shared w/mmbrs nicely green. actually sold puts to finance it so 0cost basis. 
Merck  Merck, a Dow Jones Industrial stock moved above  64.96 to an all-time high extending an intermediate uptrend 
Merck & Co  Merck market alert: 15-year high   65.46 
As  BMY is hod -  Merck bull risk reversal trades out in Jan:
2k Merck Jan 70 Calls  2.99  Above Ask!
2k Merck Jan 65 Puts  5.75  BIDSIDE
Buying  Merck here with tight stoploss, entry = 65 
 Merck breaking out
 Merck Good look. Looks like it wants to crack this level after slight dip. Like it and am long via April 65 calls 
Merck & Co  Merck market alert: 13-week high   64.96 
Close to breaking out of range -  Merck chart 
 Merck breaking out of decade long resistance
Merck's  DTC  pharma  ad for Keytruda hints at more  cancer brands turning to TV.  Merck  hcmktg‚Ä¶ 
S&P100  Stocks Trend  GD  MSFT  CAT  FDX  PCLN  Intel  UPS  FOXA  Merck  CMCSA  HAL  DOW  DD  T  EMR  USB  ALL    
Allergan Creates New Performance Bucket For Itself  AGN  VRX  JNJ  MYL  Merck  IEP  EXEL  SPY  SNY  TEVA  IPXL  KO‚Ä¶ 
 Merck Gilead Sciences: Not Out of the Woods Yet? 
 Merck [stc] FEB17  61.5 Cs   3.25 | Closed Position [+137%]
 yusschr  FilmProfessor9  NotaBubble Rather go with  Merck at basically the same price with better growth pipeline.
Merck trying to clear a range that goes back to the dot-com bubble era.  Merck
Merck trying to clear a resistance (area) that goes back to the dot-com bubble era.  Merck 
 Merck Gerberding insists  IamBiotech is 'walking the walk' on  diversity; wants to be best
 bioceo17  womeninbiotech  womeninscience  biotech
Merck didn't move needle on diversity until mandated slate of candidates for position be diverse -  Merck's Julie Gerberding  BIOCEO17
Best market technician, Tim Ord. Bull or Bear? See here.  MDT  MET  MMM  MO  MDLZ  MON  MS  Merck  MSFT  MKE  
 Merck Gerberding: There's a competitive advantage of having  diversity
 bioceo17  travelban  biotech
 Merck's Julie Gerberding: it's not just about ethnic and racial  diversity, it's about diversity with a capital "D"  BIOCEO17
 Merck former  CDC Gerberding: The diversity of US PhD level is not translating into  biotech workforce
 WomenInScience  bioceo17  STEM
Merck Top news - Feb 14th, 2017  Merck 
Seattle Turns To Buying In Growth  IMMU  Merck  RHHBY  SGEN
Merck's  DTC  pharma  ad for Keytruda hints at more  cancer brands turning to TV.  Merck  hcsm 
Hey  TheStreet  Are these all your accounts on the  AGN feed?  tst 
 VRX  TWTR  Apple  MYL  Merck  Google  JNJ  KO  PEP‚Ä¶ 
Amazing how all the pumping tweets showed back up again on the  AGN feed
 VRX  TWTR  Apple  MYL  Merck  Google  JNJ  KO‚Ä¶ 
OLD Republic International Corp Has  23,174,000 Position in  Merck & Company, Inc. (). Read more:  Merck
Piedmont Investment Advisors LLC Buys Shares of 701,274 Merck & Company, Inc.  Merck 
Weekly S&P100  Stocks Trend  DOW  DD  FDX  MSFT  CAT  FOXA  GD  PCLN  CMCSA  HAL  Intel  UPS  Merck  USB  EMR    
Weekly Dow  Stocks Trend  DD  MSFT  CAT  Intel  Merck  Boeing  CSCO  Apple  IBM  JPM  MCD  UNH  DIS  V  HD  TRV  AXP    
Price T Rowe Associates Inc. MD Acquires 16,764,608 Shares of Merck & Company, Inc.  Merck 
Merck & Company, Inc.  Merck Shares Bought by Quantitative Systematic Strategies LLC 
Merck & Company, Inc.  Merck Shares Sold by J.P. Marvel Investment Advisors LLC 
EOD Risers:  Merck & Co., Inc., Microsoft Corporation, Pfizer Inc., Procter & Gamble Co, The... Read more:  Merck
OLD Republic International Corp Has  23,174,000 Position in Merck & Company, Inc.  Merck 
 Merck  Co Partnering Deals and Alliances 2010 to 2017 Updated 01022017 Prices from USD  1495. Read more:  Merck
Adage Capital Partners GP L.L.C. Purchases 1,921,350 Shares of  Merck & Company, Inc. (). Read more:  Merck
 Merck & Co., Inc. HPV Vaccine Gardasil Sales Impress, But For How Long?. Read more:  Merck
BRIEF-Capital World Investors reports 5.1 pct passive stake in  Merck & Co as on Dec 30 - SE... Read more:  Merck
 Dow  stocks  Merck Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  
< Review of this fantastic traders teaching service!! Try it for FREE!  LLY  DGX  Merck  NVS  AMGN
 Merck These drug and medical device companies made the most payments to N.Y.C.... 
Eight Stocks To Watch This Week ‚Äì  Merck  ADSK  ACIA  ZTO  CLD  NM  OLED  
Tell  AGN  10MM CFO it's not just for mgmt.& won't be supporting stock multiple for long  VRX  TWTR  Apple  JNJ  Merck‚Ä¶ 
And The CFO Underestimates at the least! It's Not Going to Be So Easy!  AGN  VRX  MYL  Merck  JNJ  Merck  BRK  SNY‚Ä¶ 
 Merck chart via 
DOUBLE TOPS / BREAKOUTS:  X  IWM  MT  WFC  Merck  TECK  CTSH More here: 
What Happened to your missed Dates?  AGN  VRX  MYL  Merck  JNJ  Merck  BRK  SNY  SRPT  TEVA  BRK  PRGO  IEP 
Allergan's Mgmt is Bold Embarrassing Deceivers and Should Step Down! 
 AGN  VRX  MYL  Merck  JNJ  Merck  BRK  SNY  SRPT‚Ä¶ 
Name Change? How About Performance Net Income?   VRX  AGN  MYL  Merck  JNJ  SNY  PRGO  IEP  HLF  SPY  SPX  BRK  GILD‚Ä¶ 
Performance Net Income? Really? Miss The Mark?   VRX  AGN  MYL  Merck  JNJ  SNY  PRGO  IEP  HLF  SPY  SPX  BRK  GILD‚Ä¶ 
Botox-The Drug that Treats Everything! Everything?  VRX  AGN  MYL  Merck  JNJ  SNY  PRGO  IEP  HLF  SPY  SPX  BRK‚Ä¶ 
How About " I was told to by the SEC" ?  VRX  AGN  MYL  Merck  JNJ  SNY  PRGO  IEP  HLF  SPY  SPX  BRK  GILD  TEVA  SRPT  PRGO  JPM
2Sufficient Integrity for a CEO of a Drug Company?  VRX  AGN  MYL  Merck  JNJ  SNY  PRGO  IEP  HLF  SPY  SPX  BRK‚Ä¶ 
Sufficient Integrity for a CEO of a Drug Company?  VRX  AGN  MYL  Merck  JNJ  SNY  PRGO  IEP  HLF  SPY  SPX  BRK‚Ä¶ 
